Back to Search
Start Over
Developing a quality by design approach to model tablet dissolution testing: an industrial case study
- Source :
- Pharmaceutical Development and Technology, Pharmaceutical Development and Technology, Taylor & Francis, 2018, 23 (6), pp.646-654. ⟨10.1080/10837450.2017.1392566⟩
- Publication Year :
- 2018
- Publisher :
- HAL CCSD, 2018.
-
Abstract
- International audience; This study applied the concept of Quality by Design (QbD) to tablet dissolution. Its goal was to propose a quality control strategy to model dissolution testing of solid oral dose products according to International Conference on Harmonization guidelines. The methodology involved the following three steps: (1) a risk analysis to identify the material- and process-related parameters impacting the critical quality attributes of dissolution testing, (2) an experimental design to evaluate the influence of design factors (attributes and parameters selected by risk analysis) on dissolution testing, and (3) an investigation of the relationship between design factors and dissolution profiles. Results show that (a) in the case studied, the two parameters impacting dissolution kinetics are active pharmaceutical ingredient particle size distributions and tablet hardness and (b) these two parameters could be monitored with PAT tools to predict dissolution profiles. Moreover, based on the results obtained, modeling dissolution is possible. The practicality and effectiveness of the QbD approach were demonstrated through this industrial case study. Implementing such an approach systematically in industrial pharmaceutical production would reduce the need for tablet dissolution testing.
- Subjects :
- Oral dose
Quality Control
quality by design
Computer science
media_common.quotation_subject
Drug Compounding
Pharmaceutical Science
Ibuprofen
02 engineering and technology
030226 pharmacology & pharmacy
dissolution modeling
Quality by Design
03 medical and health sciences
0302 clinical medicine
Tablet dissolution
Drug Stability
X-Ray Diffraction
Hardness
[CHIM]Chemical Sciences
Quality (business)
Dissolution testing
Particle Size
Process engineering
ICH Q8 guideline
media_common
business.industry
Design of experiments
Anti-Inflammatory Agents, Non-Steroidal
risk assessment
General Medicine
021001 nanoscience & nanotechnology
Drug Liberation
design of experiments
Models, Chemical
Solubility
0210 nano-technology
business
Crystallization
Tablets
Subjects
Details
- Language :
- English
- ISSN :
- 10837450 and 10979867
- Database :
- OpenAIRE
- Journal :
- Pharmaceutical Development and Technology, Pharmaceutical Development and Technology, Taylor & Francis, 2018, 23 (6), pp.646-654. ⟨10.1080/10837450.2017.1392566⟩
- Accession number :
- edsair.doi.dedup.....19034fdeb7416cc15f45ae324f526fb2
- Full Text :
- https://doi.org/10.1080/10837450.2017.1392566⟩